Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions
Adding a second peptide that targets a completely different receptor system produces compounding effects rather than diminishing returns
In studies, participants receiving higher retatrutide doses achieved average weight reductions approaching or exceeding 24% of their starting body weight
For a 0.3 kg subject, that is 75 mcg required 0.075 mL drawn
Before you use NASCOBAL, tell your healthcare provider about all of your medical conditions, including if you: have a history of a certain disease that effects or weakens the optic nerve in your eye (early Lebers disease)
US$ 25.50
US$ 22.51
US$ 23.17
US$ 20.58
